In one paragraphArticle in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors at 4 institutions in 3 countries.
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Mary B MakariousLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-7978-1051 Peter Wild CreaLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-8944-5716 Dena G HernandezLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, United Kingdom.ORCID 0000-0002-2866-7777 Mie RizigDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, United Kingdom.ORCID 0000-0003-2420-4449 Andrew B SingletonCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-5606-700X Alastair J NoyceCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University London, London, United Kingdom.ORCID 0000-0003-3027-5497 Mike A NallsCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Cornelis BlauwendraatCenter for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-9358-8111 National Institutes of Health · USNational Hospital for Neurology and Neurosurgery · GBUniversity of Lagos · NGQueen Mary University of London · GB
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Background: Damaging coding variants in Objectives: To investigate whether the Methods: We studied 709 persons with PD and 776 neurologically healthy controls from Nigeria. The Results: The non-coding Conclusions: We show that the non-coding
Indexed as
GBA1GeneticsNigeriaNigeriansParkinson’s diseaseRBDREM parasomniaREM sleep behavior disorderrs3115534sub-Saharan Africa
Identifiers
PMID38076854
PMCPMC10705662
OpenAlexW4388449322
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390